Jeong-Min Kim

Title: Jeong-Min Kim: Innovator in Pharmaceutical Chemistry

Introduction

Jeong-Min Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on tricyclic derivative compounds.

Latest Patents

Jeong-Min Kim holds a patent for a "Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same." This invention focuses on novel tricyclic derivative compounds, including their optical isomers, racemates, and pharmaceutically acceptable salts. These compounds exhibit excellent activity against PARP-1, tankyrase-1, and tankyrase-2. The compounds are particularly valuable for the prevention or treatment of various conditions, including neuropathic pain, neurodegenerative diseases, cardiovascular diseases, diabetic neuropathy, inflammatory diseases, osteoporosis, and cancer.

Career Highlights

Jeong-Min Kim is associated with Je Il Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, contributing to the development of effective therapeutic agents.

Collaborations

He collaborates with talented colleagues, including Hyunho Lee and Kwangwoo Chun, to further enhance the impact of their research in the pharmaceutical sector.

Conclusion

Jeong-Min Kim's innovative work in developing tricyclic derivative compounds showcases his commitment to advancing medical science. His contributions have the potential to significantly improve treatment options for various diseases.